{
    "Trade/Device Name(s)": [
        "Healgen Oxazepam Test (Strip, Cassette, Cup, Dip Card)",
        "Healgen Morphine Test (Strip, Cassette, Cup, Dip Card)"
    ],
    "Submitter Information": "HEALGEN SCIENTIFIC LLC",
    "510(k) Number": "K142280",
    "Predicate Device Reference 510(k) Number(s)": [
        "K052115"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JXM",
        "DJG"
    ],
    "Summary Letter Date": "August 12, 2014",
    "Summary Letter Received Date": "August 15, 2014",
    "Submission Date": "October 6, 2014",
    "Regulation Number(s)": [
        "21 CFR 862.3170",
        "21 CFR 862.3650"
    ],
    "Regulation Name(s)": [
        "Benzodiazepine test system",
        "Opiate test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Oxazepam",
        "Morphine"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Strip",
        "Cassette",
        "Cup",
        "Dip Card"
    ],
    "Method(s)/Technology(ies)": [
        "Immunochromatographic assay",
        "Lateral flow chromatographic immunoassay",
        "Competitive binding assay"
    ],
    "Methodologies": [
        "Antigen antibody immunochemistry",
        "Lateral flow immunochromatographic testing"
    ],
    "Submission Type(s)": [
        "Strip",
        "Cassette",
        "Cup",
        "Dip Card",
        "Test Device",
        "Package Insert"
    ],
    "Document Summary": "FDA 510(k) summary for Healgen Oxazepam and Morphine rapid lateral flow urine drug tests in multiple formats (strip, cassette, cup, dip card)",
    "Indications for Use Summary": "Qualitative detection of oxazepam (benzodiazepine class) and morphine (opiate class) in human urine at defined cut-off concentrations for in vitro diagnostic use, available OTC and prescription, yielding preliminary results requiring confirmation by alternative methods",
    "fda_folder": "Toxicology"
}